日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Concordance analysis of DNA and RNA profiling: The MD Anderson IMPACT2 study in precision oncology

DNA和RNA谱分析的一致性分析:MD安德森癌症中心IMPACT2精准肿瘤学研究

Schmidt, Stephanie T; Baysal, Mehmet A; Fu, Siqing; Hong, David S; Piha-Paul, Sarina A; Naing, Aung; Rodon Ahnert, Jordi; Yap, Timothy A; Dumbrava, Ecaterina Elena; Beck, Jennifer; Meric-Bernstam, Funda; Tsimberidou, Apostolia Maria

DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix

DART/SWOG/NCI II期抗CTLA-4/PD-1试验:卵巢、子宫内膜、宫颈透明细胞癌

Chae, Young Kwang; Othus, Megan; Patel, Sandip P; Backes, Floortje J; O'Malley, David M; Cristea, Mihaela; Naing, Aung; Kurnit, Katherine; Eskander, Ramez N; T Goodrich, Scott; Robinson, William R; Scalici, Jennifer; Chan, John; Ali-Ahmad, Hussein; Hays, John; McCormick, Colleen; Kim, Edward J; Sueblinvong, Thanasak; Ahmed, Amina; Siedel, Jean; Thomes Pepin, Jessica; Bottsford-Miller, Justin Neal; Fagbemi, Seth Olusegun; Jaslowski, Anthony John; Kim, Hye Sung; Chung, Liam Il-Young; Moloney-Lineen, Carolyn; McLeod, Christine M; Chen, Helen X; Sharon, Elad; Streicher, Howard; Ryan, Christopher W; Blanke, Charles D; Kurzrock, Razelle

Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson

在MD安德森癌症中心早期临床试验中入组的晚期非小细胞肺癌患者的治疗反应

Lim, Jeong Uk; Lin, Heather Y; Kang, Lei; Le, Hung; Tang, Tin-Yun; Champiat, Stephane; Dumbrava, Ecaterina Elena; Le, Xiuning; Naing, Aung; Piha-Paul, Sarina A; Ahnert, Jordi Rodon; Tsimberidou, Apostolia Maria; Yap, Timothy A; Fu, Siqing; Meric-Bernstam, Funda; Hong, David S

Phase I study of bevacizumab and temsirolimus combination therapy in advanced malignancies: safety, efficacy, and ovarian cancer expansion

贝伐珠单抗联合替西罗莫司治疗晚期恶性肿瘤的I期研究:安全性、疗效及卵巢癌扩展研究

Piha-Paul, Sarina A; Tseng, Chieh; Thompson, Emily; Stafford, R Jason; Le, Hung; Kang, Lei; Fu, Siqing; Tsimberidou, Apostolia; Blumenschein, George; Ahnert, Jordi Rodon; Slopis, John M; Hong, David; Naing, Aung; Meric-Bernstam, Funda; Ng, Chaan S; Westin, Shannon; Sood, Anil K

Telemedicine as a gateway to early-phase oncology trials: lessons from 14 000 patients and future directions for global access and equity

远程医疗作为早期肿瘤临床试验的途径:来自14000名患者的经验教训以及全球可及性和公平性的未来方向

Torrado, Carlos; Andersen, Clark R; Kang, Lei; Brink, Amanda L; Adesoye, Taiwo; Le, Hung; Patterson, Clover J; Poullard, Anna; Osburn, Jessica A; Tan, Harold N; Gouda, Mohamed A; Charles, Sheena; Urschel, Gabriele E; Tang, Tin-Yun; Hong, David S; Champiat, Stephane; Naing, Aung; Tsimberidou, Apostolia M; Dumbrava, Ecaterina E; Piha-Paul, Sarina A; Rodon, Jordi; Yap, Timothy A; Pohlmann, Paula R; Meric-Bernstam, Funda; Fu, Siqing

First-in-Human Phase I Study of KPT-9274, a First-in-Class Dual Inhibitor of PAK4 and NAMPT, in Patients with Advanced Solid Malignancies

KPT-9274(一种首创的PAK4和NAMPT双重抑制剂)在晚期实体恶性肿瘤患者中的首次人体I期研究

Razak, Albiruni; Mahipal, Amit; Diamond, Jennifer R; Ribas, Antoni; Berlin, Jordan David; Azmi, Asfar S; Mark, Tomer; Walker, Christopher J; Chai, Yi; Kashyap, Trinayan; Gudi, Girish; Naing, Aung

Inducible T-Cell Co-Stimulator (ICOS) and ICOS Ligand: Dealing With a Two-Faced Cancer Immunoregulatory System

诱导型T细胞共刺激分子(ICOS)和ICOS配体:应对癌症免疫调节系统的双重作用

Nikanjam, Mina; Kato, Shumei; Nishizaki, Daisuke; Miyashita, Hirotaka; Pabla, Sarabjot; Nesline, Mary K; Ko, Heidi; Conroy, Jeffrey M; Naing, Aung; Kurzrock, Razelle

Tumor microenvironment changes after treatment with avelumab and immune-stimulating agent combinations in patients with advanced solid tumors

阿维鲁单抗联合免疫刺激剂治疗晚期实体瘤患者后肿瘤微环境的变化

Lermi, Nejla Ozirmak; Gouda, Mohamed A; Ahmed, Jibran; Jiang, Xianli; Lee, Younghee; Mohanty, Vakul; Derbala, Mohamed; Stephen, Bettzy; Jhingran, Anuja; Mohammad, Mohammad Moustafa; Joo, Donghyun; Francisco-Cruz, Alejandro; Chen, Honglei; Calderon, Luis Acosta; Laberiano, Caddie; Arrechedera, Claudio; Pandurengan, Renganayaki; Gurses, Serdar; Yang, Yali; Solis Soto, Luisa M; Ahnert, Jordi Rodon; Chen, Ken; Meric-Bernstam, Funda; Koay, Eugene Jon; Javle, Milind; Haymaker, Cara; Naing, Aung

Phase I study of BMS-986299, an NLRP3 agonist, as monotherapy and in combination with nivolumab and ipilimumab in patients with advanced solid tumors

BMS-986299(一种 NLRP3 激动剂)单药治疗以及与纳武利尤单抗和伊匹木单抗联合治疗晚期实体瘤患者的 I 期研究

Nelson, Blessie E; O'Brien, Shaun; Sheth, Rahul A; Hong, David S; Naing, Aung; Zhang, Xiaoping; Xu, Amy; Hamuro, Lora; Suryawanshi, Rasika; McKinley, Derrick; Novosiadly, Ruslan D; Piha-Paul, Sarina A

TIGIT inhibitor M6223 as monotherapy or in combination with bintrafusp alfa in patients with advanced solid tumors: a first-in-human, phase 1, dose-escalation trial

TIGIT抑制剂M6223单药治疗或与bintrafusp alfa联合治疗晚期实体瘤患者:一项首次人体I期剂量递增试验

Naing, Aung; McKean, Meredith; Tolcher, Anthony; Victor, Anja; Hu, Ping; Gao, Wei; Nogueira Filho, Marco A F; Kitzing, Thomas; Gleicher, Stephan; Holland, Daniel; Richter, Emilia; Tadjalli-Mehr, Keyvan; Siu, Lillian L